Everdime Technologies, Inc.

RGST · OTC
Analyze with AI
3/31/2024
9/30/2023
6/30/2023
3/31/2023
Operating Activities
Net Income$39-$73$2-$434
Dep. & Amort.$15$0$0$12
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$11$47$17$30
Other Non-Cash$41-$63-$17$340
Operating Cash Flow$45-$42$19-$45
Investing Activities
PP&E Inv.$0$0$0-$5
Net Acquisitions-$22$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$22$0$0-$5
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$18-$2$0$0
Financing Cash Flow$18-$2$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash$50-$45$19-$50
Supplemental Information
Beg. Cash$5$50$30$80
End Cash$55$5$50$30
Free Cash Flow$45-$42$19-$50
Everdime Technologies, Inc. (RGST) Financial Statements & Key Stats | AlphaPilot